Healthcare provider profile · identity verified

Nancy Jane Forgy, DNP

Nurse Practitioner · COLUMBIA, MO · NPI 1225690019

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	433	110
Amlodipine Besylate	Amlodipine Besylate	302	72
Lisinopril	Lisinopril	235	60
Gabapentin	Gabapentin	215	49
Omeprazole	Omeprazole	191	44
Levothyroxine Sodium	Levothyroxine Sodium	167	40
Albuterol Sulfate Hfa	Albuterol Sulfate	163	49
Fluticasone Propionate	Fluticasone Propionate	146	47
Trazodone Hcl	Trazodone Hcl	120	21
Losartan Potassium	Losartan Potassium	114	26
Duloxetine Hcl	Duloxetine Hcl	111	19
Tizanidine Hcl	Tizanidine Hcl	105	23
Metformin Hcl	Metformin Hcl	100	28
Farxiga	Dapagliflozin Propanediol	85	20
Pantoprazole Sodium	Pantoprazole Sodium	82	21
Hydrochlorothiazide	Hydrochlorothiazide	78	23
Metformin Hcl Er	Metformin Hcl	71	16
Tramadol Hcl	Tramadol Hcl	70	23
Ozempic	Semaglutide	67	12
Metoprolol Succinate	Metoprolol Succinate	63	20
Montelukast Sodium	Montelukast Sodium	62	13
Mounjaro	Tirzepatide	62	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	15
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Ventolin Hfa	Albuterol Sulfate	52	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	17
Famotidine	Famotidine	48	11
Carvedilol	Carvedilol	47	15
Ezetimibe	Ezetimibe	47	11
Meloxicam	Meloxicam	46	11
Diclofenac Sodium	Diclofenac Sodium	45	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	42	suppressed
Ammonium Lactate	Ammonium Lactate	41	suppressed
Furosemide	Furosemide	41	15
Triamcinolone Acetonide	Triamcinolone Acetonide	40	19
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Chlorthalidone	Chlorthalidone	38	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Potassium Chloride	Potassium Chloride	37	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	36	20
Hydroxyzine Hcl	Hydroxyzine Hcl	35	11
Sertraline Hcl	Sertraline Hcl	35	suppressed
Topiramate	Topiramate	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Naproxen	Naproxen	34	12
Allopurinol	Allopurinol	33	suppressed
Tresiba Flextouch U-100	Insulin Degludec	33	suppressed
Baclofen	Baclofen	31	suppressed
Linzess	Linaclotide	31	suppressed
Jardiance	Empagliflozin	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Spiriva Respimat	Tiotropium Bromide	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Prazosin Hcl	Prazosin Hcl	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Telmisartan	Telmisartan	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Eliquis	Apixaban	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Prednisone	Prednisone	22	19
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Methylprednisolone	Methylprednisolone	19	13
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Lidocaine	Lidocaine	16	suppressed
Ondansetron Odt	Ondansetron	16	11
Risperidone	Risperidone	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Azithromycin	Azithromycin	14	14
Single Use Swab	Alcohol Antiseptic Pads	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Humira Pen	Adalimumab	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Nystatin	Nystatin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error